Targeting PLK1 as a novel chemopreventive approach to eradicate preneoplastic mucosal changes in the head and neck

Head and neck squamous cell carcinomas (HNSCC) and local relapses thereof develop in preneoplastic fields in the mucosal linings of the upper aerodigestive tract. These fields are characterized by tumor-associated genetic changes, are frequently dysplastic and occasionally macroscopically visible. C...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Oncotarget Ročník 8; číslo 58; s. 97928
Hlavní autori: de Boer, D Vicky, Martens-de Kemp, Sanne R, Buijze, Marijke, Stigter-van Walsum, Marijke, Bloemena, Elisabeth, Dietrich, Ralf, Leemans, C René, van Beusechem, Victor W, Braakhuis, Boudewijn J M, Brakenhoff, Ruud H
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: United States 17.11.2017
Predmet:
polo-like kinase 1
siRNA screening
preneoplastic fields
head and neck squamous cell carcinoma
targeted treatment
ISSN:1949-2553, 1949-2553
On-line prístup:Zistit podrobnosti o prístupe
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract Head and neck squamous cell carcinomas (HNSCC) and local relapses thereof develop in preneoplastic fields in the mucosal linings of the upper aerodigestive tract. These fields are characterized by tumor-associated genetic changes, are frequently dysplastic and occasionally macroscopically visible. Currently, no adequate treatment options exist to prevent tumor development. Array-based screening with a panel of tumor-lethal small interfering RNAs (siRNAs) identified ( ) as essential for survival of preneoplastic cells. Inhibition of PLK1 caused cell death of preneoplastic and HNSCC cells, while primary cells were hardly affected. Both siRNAs and small molecule inhibitors caused a strong G2/M cell cycle arrest accompanied by formation of monopolar spindles. In a xenografted mouse model PLK1 caused a significant tumor growth delay and cures, while chemoradiation had no effect. Thus, PLK1 seems to be a promising target for chemopreventive treatment of preneoplastic cells, and could be applied to prevent HNSCC and local relapses.
AbstractList Head and neck squamous cell carcinomas (HNSCC) and local relapses thereof develop in preneoplastic fields in the mucosal linings of the upper aerodigestive tract. These fields are characterized by tumor-associated genetic changes, are frequently dysplastic and occasionally macroscopically visible. Currently, no adequate treatment options exist to prevent tumor development. Array-based screening with a panel of tumor-lethal small interfering RNAs (siRNAs) identified Polo-like kinase 1 (PLK1) as essential for survival of preneoplastic cells. Inhibition of PLK1 caused cell death of preneoplastic and HNSCC cells, while primary cells were hardly affected. Both siRNAs and small molecule inhibitors caused a strong G2/M cell cycle arrest accompanied by formation of monopolar spindles. In a xenografted mouse model PLK1 caused a significant tumor growth delay and cures, while chemoradiation had no effect. Thus, PLK1 seems to be a promising target for chemopreventive treatment of preneoplastic cells, and could be applied to prevent HNSCC and local relapses.Head and neck squamous cell carcinomas (HNSCC) and local relapses thereof develop in preneoplastic fields in the mucosal linings of the upper aerodigestive tract. These fields are characterized by tumor-associated genetic changes, are frequently dysplastic and occasionally macroscopically visible. Currently, no adequate treatment options exist to prevent tumor development. Array-based screening with a panel of tumor-lethal small interfering RNAs (siRNAs) identified Polo-like kinase 1 (PLK1) as essential for survival of preneoplastic cells. Inhibition of PLK1 caused cell death of preneoplastic and HNSCC cells, while primary cells were hardly affected. Both siRNAs and small molecule inhibitors caused a strong G2/M cell cycle arrest accompanied by formation of monopolar spindles. In a xenografted mouse model PLK1 caused a significant tumor growth delay and cures, while chemoradiation had no effect. Thus, PLK1 seems to be a promising target for chemopreventive treatment of preneoplastic cells, and could be applied to prevent HNSCC and local relapses.
Head and neck squamous cell carcinomas (HNSCC) and local relapses thereof develop in preneoplastic fields in the mucosal linings of the upper aerodigestive tract. These fields are characterized by tumor-associated genetic changes, are frequently dysplastic and occasionally macroscopically visible. Currently, no adequate treatment options exist to prevent tumor development. Array-based screening with a panel of tumor-lethal small interfering RNAs (siRNAs) identified ( ) as essential for survival of preneoplastic cells. Inhibition of PLK1 caused cell death of preneoplastic and HNSCC cells, while primary cells were hardly affected. Both siRNAs and small molecule inhibitors caused a strong G2/M cell cycle arrest accompanied by formation of monopolar spindles. In a xenografted mouse model PLK1 caused a significant tumor growth delay and cures, while chemoradiation had no effect. Thus, PLK1 seems to be a promising target for chemopreventive treatment of preneoplastic cells, and could be applied to prevent HNSCC and local relapses.
Author Buijze, Marijke
Stigter-van Walsum, Marijke
Dietrich, Ralf
Leemans, C René
Braakhuis, Boudewijn J M
van Beusechem, Victor W
Martens-de Kemp, Sanne R
Bloemena, Elisabeth
Brakenhoff, Ruud H
de Boer, D Vicky
Author_xml – sequence: 1
  givenname: D Vicky
  surname: de Boer
  fullname: de Boer, D Vicky
  organization: Department of Otolaryngology-Head and Neck Surgery, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands
– sequence: 2
  givenname: Sanne R
  surname: Martens-de Kemp
  fullname: Martens-de Kemp, Sanne R
  organization: Department of Otolaryngology-Head and Neck Surgery, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands
– sequence: 3
  givenname: Marijke
  surname: Buijze
  fullname: Buijze, Marijke
  organization: Department of Otolaryngology-Head and Neck Surgery, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands
– sequence: 4
  givenname: Marijke
  surname: Stigter-van Walsum
  fullname: Stigter-van Walsum, Marijke
  organization: Department of Otolaryngology-Head and Neck Surgery, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands
– sequence: 5
  givenname: Elisabeth
  surname: Bloemena
  fullname: Bloemena, Elisabeth
  organization: Department of Maxillofacial Surgery/Oral Pathology, Academic Center for Dentistry Amsterdam (ACTA), Amsterdam, The Netherlands
– sequence: 6
  givenname: Ralf
  surname: Dietrich
  fullname: Dietrich, Ralf
  organization: German Fanconi-Anemia-Help e.V., Unna-Siddinghausen, Germany
– sequence: 7
  givenname: C René
  surname: Leemans
  fullname: Leemans, C René
  organization: Department of Otolaryngology-Head and Neck Surgery, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands
– sequence: 8
  givenname: Victor W
  surname: van Beusechem
  fullname: van Beusechem, Victor W
  organization: Department of Medical Oncology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands
– sequence: 9
  givenname: Boudewijn J M
  surname: Braakhuis
  fullname: Braakhuis, Boudewijn J M
  organization: Department of Otolaryngology-Head and Neck Surgery, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands
– sequence: 10
  givenname: Ruud H
  surname: Brakenhoff
  fullname: Brakenhoff, Ruud H
  organization: Department of Otolaryngology-Head and Neck Surgery, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29228663$$D View this record in MEDLINE/PubMed
BookMark eNpNkEtPwzAQhC0EoqX0B3BBPnJJsZ2XfUQVL1EJDuUcbZx1E0jsEDuV-PcEKBJ7mT18O5rZM3JsnUVCLjhbcZnF4tpZ7QIMOwwrnkvJjsicq0RFIk3j43_7jCy9f2PTpEkuhTolM6GEkFkWz8mw_XFo7I6-bJ44BU-BWrfHluoaO9cPuEcbmj1S6PvBga5pcBQHqBoNAekEWHR9Cz40mnajdh6-b8Hu0NPG0lAjrREqCraiFvX7OTkx0HpcHnRBXu9ut-uHaPN8_7i-2UQ6VipEKQIipCwtcyYzk8Qml4bHUy0NVSlNWYpYKyOM4JhIKSCRLAEjtAQFWVWJBbn69Z1if4zoQ9E1XmPbwhR49AVXecaYUJxP6OUBHcsOq6Ifmg6Gz-LvT-ILNedwZA
CitedBy_id crossref_primary_10_1016_j_ctro_2020_11_012
crossref_primary_10_1038_nrc_2018_11
crossref_primary_10_1007_s12094_020_02462_z
crossref_primary_10_3390_cancers14071815
crossref_primary_10_3390_cells13080710
crossref_primary_10_1038_s41389_024_00525_2
crossref_primary_10_1016_j_oraloncology_2019_09_004
crossref_primary_10_1158_1541_7786_MCR_18_0445
crossref_primary_10_3390_biomedicines12030503
crossref_primary_10_3390_cancers13112635
crossref_primary_10_3390_ijms252211958
crossref_primary_10_1038_s41598_025_85568_0
crossref_primary_10_3390_ph15050523
ContentType Journal Article
DBID NPM
7X8
DOI 10.18632/oncotarget.17880
DatabaseName PubMed
MEDLINE - Academic
DatabaseTitle PubMed
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
EISSN 1949-2553
ExternalDocumentID 29228663
Genre Journal Article
GroupedDBID ---
53G
ADBBV
ADRAZ
AENEX
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
DIK
FRJ
GX1
HYE
KQ8
M48
M~E
NPM
OK1
PGMZT
RPM
7X8
ID FETCH-LOGICAL-c399t-5eaeea505b7086f43f78f13194cadb8fbb23c9f2f21e4882a4804af2c8a9a6dd2
IEDL.DBID 7X8
ISICitedReferencesCount 21
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000419392300020&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1949-2553
IngestDate Sun Nov 09 10:34:35 EST 2025
Wed Feb 19 02:42:27 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 58
Keywords polo-like kinase 1
siRNA screening
preneoplastic fields
head and neck squamous cell carcinoma
targeted treatment
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c399t-5eaeea505b7086f43f78f13194cadb8fbb23c9f2f21e4882a4804af2c8a9a6dd2
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC5716703
PMID 29228663
PQID 1976002911
PQPubID 23479
ParticipantIDs proquest_miscellaneous_1976002911
pubmed_primary_29228663
PublicationCentury 2000
PublicationDate 2017-11-17
PublicationDateYYYYMMDD 2017-11-17
PublicationDate_xml – month: 11
  year: 2017
  text: 2017-11-17
  day: 17
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Oncotarget
PublicationTitleAlternate Oncotarget
PublicationYear 2017
References 19433805 - Proc Natl Acad Sci U S A. 2009 May 26;106(21):8695-700
15173066 - Clin Cancer Res. 2004 Jun 1;10(11):3607-13
15458642 - Curr Biol. 2004 Oct 5;14 (19):1712-22
22147262 - Cancer Res. 2012 Feb 1;72(3):757-68
16885335 - Cancer Res. 2006 Aug 1;66(15):7405-13
26769431 - JAMA Otolaryngol Head Neck Surg. 2016 Mar;142(3):209-16
25524551 - Cancer Lett. 2015 Feb 28;357(2):591-601
24954208 - Nat Rev Mol Cell Biol. 2014 Jul;15(7):433-52
16627997 - Cell Cycle. 2006 Apr;5(8):853-64
18674954 - Oral Oncol. 2009 Apr-May;45(4-5):317-23
21459796 - Clin Cancer Res. 2011 May 15;17(10):3420-30
22119200 - Eur J Cancer. 2012 Jan;48(2):179-86
21160525 - Nat Rev Cancer. 2011 Jan;11(1):9-22
23444224 - Clin Cancer Res. 2013 Apr 15;19(8):1994-2003
22911111 - Cancer Prev Res (Phila). 2012 Sep;5(9):1081-9
14740490 - Biotechniques. 2004 Jan;36(1):84-6, 88, 90-1
11410486 - Clin Cancer Res. 2001 Jun;7(6):1523-32
19996216 - Clin Cancer Res. 2009 Dec 15;15(24):7666-7675
17312569 - Head Neck. 2007 Feb;29(2):163-88
18154571 - J Oral Pathol Med. 2008 Jan;37(1):1-10
21351269 - Int J Cancer. 2010 Dec 15;127(12):2893-917
12782571 - Cancer Res. 2003 Jun 1;63(11):2705-15
25808837 - Mol Cancer Ther. 2015 Jun;14 (6):1434-44
19458358 - Blood. 2009 Jul 16;114(3):659-62
17121891 - Clin Cancer Res. 2006 Nov 15;12(22):6716-22
21880540 - Oral Oncol. 2011 Oct;47(10):956-60
16557283 - Nat Rev Cancer. 2006 Apr;6(4):321-30
12579537 - J Pathol. 2003 Mar;199(3):354-60
27980104 - Mol Cancer Ther. 2017 Mar;16(3):540-550
15761500 - J Clin Invest. 2005 Apr;115(4):978-85
16819514 - Oncogene. 2007 Jan 4;26(1):54-64
22714984 - Head Neck. 2013 Apr;35(4):568-74
19383823 - Clin Cancer Res. 2009 May 1;15(9):3094-102
23523931 - Stem Cell Res. 2013 May;10(3):477-88
10383133 - Cancer Res. 1999 Jun 15;59(12):2794-7
19474163 - Oncologist. 2009 Jun;14(6):559-70
12702551 - Cancer Res. 2003 Apr 15;63(8):1727-30
16316774 - Oral Oncol. 2006 May;42(5):461-74
8824719 - Genes Chromosomes Cancer. 1996 Jan;15(1):1-9
20568113 - Int J Cancer. 2011 Apr 15;128(8):1852-9
23525475 - J Gerontol A Biol Sci Med Sci. 2013 Oct;68(10):1145-56
References_xml – reference: 21160525 - Nat Rev Cancer. 2011 Jan;11(1):9-22
– reference: 19383823 - Clin Cancer Res. 2009 May 1;15(9):3094-102
– reference: 23444224 - Clin Cancer Res. 2013 Apr 15;19(8):1994-2003
– reference: 20568113 - Int J Cancer. 2011 Apr 15;128(8):1852-9
– reference: 16627997 - Cell Cycle. 2006 Apr;5(8):853-64
– reference: 25808837 - Mol Cancer Ther. 2015 Jun;14 (6):1434-44
– reference: 18154571 - J Oral Pathol Med. 2008 Jan;37(1):1-10
– reference: 16885335 - Cancer Res. 2006 Aug 1;66(15):7405-13
– reference: 12579537 - J Pathol. 2003 Mar;199(3):354-60
– reference: 11410486 - Clin Cancer Res. 2001 Jun;7(6):1523-32
– reference: 22714984 - Head Neck. 2013 Apr;35(4):568-74
– reference: 18674954 - Oral Oncol. 2009 Apr-May;45(4-5):317-23
– reference: 16316774 - Oral Oncol. 2006 May;42(5):461-74
– reference: 24954208 - Nat Rev Mol Cell Biol. 2014 Jul;15(7):433-52
– reference: 16557283 - Nat Rev Cancer. 2006 Apr;6(4):321-30
– reference: 15173066 - Clin Cancer Res. 2004 Jun 1;10(11):3607-13
– reference: 22119200 - Eur J Cancer. 2012 Jan;48(2):179-86
– reference: 22911111 - Cancer Prev Res (Phila). 2012 Sep;5(9):1081-9
– reference: 19458358 - Blood. 2009 Jul 16;114(3):659-62
– reference: 19996216 - Clin Cancer Res. 2009 Dec 15;15(24):7666-7675
– reference: 8824719 - Genes Chromosomes Cancer. 1996 Jan;15(1):1-9
– reference: 14740490 - Biotechniques. 2004 Jan;36(1):84-6, 88, 90-1
– reference: 23525475 - J Gerontol A Biol Sci Med Sci. 2013 Oct;68(10):1145-56
– reference: 23523931 - Stem Cell Res. 2013 May;10(3):477-88
– reference: 10383133 - Cancer Res. 1999 Jun 15;59(12):2794-7
– reference: 16819514 - Oncogene. 2007 Jan 4;26(1):54-64
– reference: 27980104 - Mol Cancer Ther. 2017 Mar;16(3):540-550
– reference: 26769431 - JAMA Otolaryngol Head Neck Surg. 2016 Mar;142(3):209-16
– reference: 21459796 - Clin Cancer Res. 2011 May 15;17(10):3420-30
– reference: 15458642 - Curr Biol. 2004 Oct 5;14 (19):1712-22
– reference: 21880540 - Oral Oncol. 2011 Oct;47(10):956-60
– reference: 19433805 - Proc Natl Acad Sci U S A. 2009 May 26;106(21):8695-700
– reference: 22147262 - Cancer Res. 2012 Feb 1;72(3):757-68
– reference: 19474163 - Oncologist. 2009 Jun;14(6):559-70
– reference: 12702551 - Cancer Res. 2003 Apr 15;63(8):1727-30
– reference: 15761500 - J Clin Invest. 2005 Apr;115(4):978-85
– reference: 21351269 - Int J Cancer. 2010 Dec 15;127(12):2893-917
– reference: 25524551 - Cancer Lett. 2015 Feb 28;357(2):591-601
– reference: 17121891 - Clin Cancer Res. 2006 Nov 15;12(22):6716-22
– reference: 17312569 - Head Neck. 2007 Feb;29(2):163-88
– reference: 12782571 - Cancer Res. 2003 Jun 1;63(11):2705-15
SSID ssj0000547829
Score 2.2815404
Snippet Head and neck squamous cell carcinomas (HNSCC) and local relapses thereof develop in preneoplastic fields in the mucosal linings of the upper aerodigestive...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 97928
Title Targeting PLK1 as a novel chemopreventive approach to eradicate preneoplastic mucosal changes in the head and neck
URI https://www.ncbi.nlm.nih.gov/pubmed/29228663
https://www.proquest.com/docview/1976002911
Volume 8
WOSCitedRecordID wos000419392300020&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8NAEF7UevDiA1_1xQhe1ya7MZs9iYhFsJYeKvQW9hUoalKb2t_v7CbVkyB4yW3DPubxzc63M4RcpSblOo0ST6vgNNHSUW2ZoIZFOrHKWNaUzB-I4TCbTOSovXCrW1rlyiYGQ20r4-_Ie7FsUkhxfDv7oL5rlM-uti001kmHI5TxlC4xyb7vWCJfrCo0KsNQXVJEz7xNbGYpZ73Klz8IfOvrGCPB6HeQGZxNf-e_09wl2y3MhLtGLvbImiv3yXwcpoHOCkaDpxhUDQrKauneAI_u3fdDCezHpYNVqXFYVODmyoaXchDqX1YzBNz4W3j3ZHflx_oHCjVMS0A0CWjdLajSQunM6wF56T-M7x9p23OBGoQqC3rjlHMKYZEWGOwUCS9EVsSop4lRVmeF1owbWbCCxQ51n6kkixJVMJMpqVJr2SHZKKvSHRNIrYiki4RLWZwgrFAWbQFnWnHtu5ulXXK52sIcZdonKhQu4rPOfzaxS46ac8hnTfGNnEnGMoRJJ38YfUq2mPfCnrUnzkinQI1252TTLBfTen4RhAW_w9HzF6Shy2A
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Targeting+PLK1+as+a+novel+chemopreventive+approach+to+eradicate+preneoplastic+mucosal+changes+in+the+head+and+neck&rft.jtitle=Oncotarget&rft.au=de+Boer%2C+D+Vicky&rft.au=Martens-de+Kemp%2C+Sanne+R&rft.au=Buijze%2C+Marijke&rft.au=Stigter-van+Walsum%2C+Marijke&rft.date=2017-11-17&rft.issn=1949-2553&rft.eissn=1949-2553&rft.volume=8&rft.issue=58&rft.spage=97928&rft_id=info:doi/10.18632%2Foncotarget.17880&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1949-2553&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1949-2553&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1949-2553&client=summon